Actively Recruiting
Study Evaluating the Impact of Using Triplex Rapid Diagnostic Tests (SARS-CoV-2/Influenza/RSV) on Antibiotic Prescribing
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-01-14
2000
Participants Needed
1
Research Sites
12 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Respiratory infections are very common, especially during winter, and are often caused by viruses such as influenza, SARS-CoV-2 or respiratory syncytial virus (RSV). These illnesses are generally mild, but their symptoms do not always allow a clear distinction to be made between a viral infection and a bacterial infection. In the absence of a precise diagnosis, antibiotics may be prescribed when they are not necessary in many cases. However, the excessive use of antibiotics contributes to the development of bacterial resistance, which is a major public health issue. The aim of this study is to better understand whether the use of a rapid test (called TROD), which can quickly identify certain respiratory viruses, can help doctors reduce unnecessary antibiotic prescriptions for these infections. The test will be performed using a swab gently inserted into the nose.
CONDITIONS
Official Title
Study Evaluating the Impact of Using Triplex Rapid Diagnostic Tests (SARS-CoV-2/Influenza/RSV) on Antibiotic Prescribing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 1 year or older
- Presenting with fever over 38°C within the past 72 hours and symptoms such as rhinorrhea, nasal obstruction, cough, body aches, fatigue, sore throat with negative strepto-test, or ear pain
- Or suspected lower respiratory tract infection with signs like rapid breathing, fast heart rate, fatigue, cough, sputum, chest pain, or abnormal lung sounds
- Affiliated with the national health insurance system
- Informed consent obtained from adult participants or guardians for minors
You will not qualify if you...
- Requirement for hospitalization
- Having a non-respiratory infection requiring antibiotic treatment
- Patients covered by State Medical Aid (AME)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Assistance Publique - Hôpitaux de Paris
Garches, France
Actively Recruiting
Research Team
A
Aurélien DINH, MD, PhD
CONTACT
J
Jacques ROPERS, PharmD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
FACTORIAL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here